Well, what I've noticed as one of the most profound You know, outcomes of my analysis of my patients is these people, these people's disordered eating is healing
For plateau situations where weight loss stalls, strategies beyond dose escalation often prove more effective
Lancet Gastroenterol Hepatol 2022;7(10):92231
Abstract Purpose of Review To discuss evidence supporting the use of glucagon-like peptide 1 receptor agonists (GLP-1RA) to treat obesity and their role as a cardioprotective drug
It is a safe, fast and effective way to deliver critical nutrients into your body for intracellular bioavailability
If you experience severe, persistent abdominal pain while taking GLP-1 medications, stop taking the medication and seek urgent medical attention, as this could indicate pancreatitis or gallbladder disease